194 related articles for article (PubMed ID: 8596138)
1. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells.
Sugiyama E; Kuroda A; Taki H; Ikemoto M; Hori T; Yamashita N; Maruyama M; Kobayashi M
J Rheumatol; 1995 Nov; 22(11):2020-6. PubMed ID: 8596138
[TBL] [Abstract][Full Text] [Related]
2. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines.
Chabaud M; Fossiez F; Taupin JL; Miossec P
J Immunol; 1998 Jul; 161(1):409-14. PubMed ID: 9647250
[TBL] [Abstract][Full Text] [Related]
4. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Harada S; Yamamura M; Okamoto H; Morita Y; Kawashima M; Aita T; Makino H
Arthritis Rheum; 1999 Jul; 42(7):1508-16. PubMed ID: 10403280
[TBL] [Abstract][Full Text] [Related]
5. Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis.
Chenevier-Gobeaux C; Morin-Robinet S; Lemarechal H; Poiraudeau S; Ekindjian JC; Borderie D
Clin Sci (Lond); 2004 Sep; 107(3):291-6. PubMed ID: 15149282
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo.
Woods JM; Tokuhira M; Berry JC; Katschke KJ; Kurata H; Damergis JA; Arai K; Koch AE
J Investig Med; 1999 Jul; 47(6):285-92. PubMed ID: 10431483
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
[TBL] [Abstract][Full Text] [Related]
9. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
10. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
11. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
Chabaud M; Durand JM; Buchs N; Fossiez F; Page G; Frappart L; Miossec P
Arthritis Rheum; 1999 May; 42(5):963-70. PubMed ID: 10323452
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
Cho ML; Jung YO; Moon YM; Min SY; Yoon CH; Lee SH; Park SH; Cho CS; Jue DM; Kim HY
Immunol Lett; 2006 Mar; 103(2):159-66. PubMed ID: 16368150
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
[TBL] [Abstract][Full Text] [Related]
15. FK506, an immunosuppressant, partially inhibits interleukin 6 production by adherent rheumatoid synovial cells.
Sugiyama E; Suzuki H; Tunru IS; Yamashita N; Hori T; Kobayashi M
J Rheumatol; 1994 Sep; 21(9):1597-601. PubMed ID: 7528280
[TBL] [Abstract][Full Text] [Related]
16. Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: a novel mechanism of activation of synoviocytes.
Harigai M; Hara M; Nakazawa S; Fukasawa C; Ohta S; Sugiura T; Inoue K; Kashiwazaki S
J Rheumatol; 1999 May; 26(5):1035-43. PubMed ID: 10332965
[TBL] [Abstract][Full Text] [Related]
17. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.
Chomarat P; Vannier E; Dechanet J; Rissoan MC; Banchereau J; Dinarello CA; Miossec P
J Immunol; 1995 Feb; 154(3):1432-9. PubMed ID: 7822808
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes.
Dechanet J; Taupin JL; Chomarat P; Rissoan MC; Moreau JF; Banchereau J; Miossec P
Eur J Immunol; 1994 Dec; 24(12):3222-8. PubMed ID: 7805751
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
20. Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
Minghetti PP; Blackburn WD
J Rheumatol; 2000 Mar; 27(3):653-60. PubMed ID: 10743803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
